Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019
The coronavirus disease 2019 (COVID-19) pandemic started in Wuhan, Hubei Province, China, in December 2019, and by 24 April 2020, it had affected >2.73 million people in 185 countries and caused >192,000 deaths. Despite diverse societal measures to reduce transmission of the severe acute respi...
Guardado en:
Autores principales: | Ernest Spitzer, Ben Ren, Jasper J Brugts, Joost Daemen, Eugene McFadden, Jan GP Tijssen, Nicolas M Van Mieghem |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1ebdf01778c24f519e49f3107d6ea9f3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
2019 novel-coronavirus: Cardiovascular insights about risk factors, myocardial injury, therapy and clinical implications
por: Luigi Cappannoli, et al.
Publicado: (2020) -
Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
por: Maki Komiyama, et al.
Publicado: (2021) -
Cardiovascular Medical Education During the Coronavirus Disease 2019 Pandemic: Challenges, Adaptations, and Considerations for the Future
por: Hilary Shapiro, et al.
Publicado: (2021) -
Sleep Quality During Coronavirus-2019 Pandemic
por: Farzin Bagheri Sheykhangafshe, et al.
Publicado: (2021) -
Editorial: Ethnopharmacological Responses to the Coronavirus Disease 2019 Pandemic
por: Jia-bo Wang, et al.
Publicado: (2021)